openPR Logo
Press release

Analysis of Segments and Major Growth Areas in the Transdermal Skin Patches Market

12-17-2025 09:48 AM CET | Health & Medicine

Press release from: The Business Research Company

Transdermal Skin Patches Market

Transdermal Skin Patches Market

The transdermal skin patches market is set to experience consistent growth over the coming years, driven by several health and technological factors. This report explores the market's size projections, key players, emerging trends, and detailed segment analysis, offering a clear picture of where the industry is headed.

Projected Market Size and Expansion of the Transdermal Skin Patches Market
The transdermal skin patches market is anticipated to reach $9.18 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.7%. This upward trajectory is mainly fueled by increased efforts for smoking cessation, a rapidly aging population, rising healthcare spending, and a higher prevalence of cardiovascular diseases. Additional factors like technological advancements in patch design, progress in diabetes-related patches, vigorous R&D activities, product innovation, strategic partnerships, and the rise of wearable skin patches further contribute to the market's expansion. Developments in microneedle patches for vaccinations and new iontophoresis patch technologies are also important trends shaping the future of this sector.

Download a free sample of the transdermal skin patches market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2829&type=smp

Key Market Drivers Encouraging Growth in Transdermal Skin Patches
One important driver for this market is the growing emphasis on smoking cessation, which has spurred demand for nicotine patches as effective aids. As more people seek non-invasive and convenient treatment options, transdermal patches are becoming increasingly popular.
Another significant factor is the aging global population, which often faces chronic health conditions requiring ongoing medication. This demographic shift is leading to higher healthcare expenditures and increased use of patches designed for cardiovascular and other age-related ailments.

Leading Companies Influencing the Transdermal Skin Patches Market
Several prominent companies are active players in this market, including Novartis, Hisamitsu Pharmaceutical Co., Inc., Henan Lingrui Pharmaceutical, Teva Pharmaceuticals, Luye Pharma Group Ltd, Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc., 3M Company, Acrux Ltd, Access Pharmaceuticals Inc., Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd, Mundipharma, Dr Reddy's Laboratories, Chattem, Clarity Medical, Welcare Industries S.P.A., F.L. Medical S.r.l, Europlaz Technologies Ltd, Zentiva, Medical-Lomza Sp. z o.o., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, and Endo Pharmaceuticals Inc.
A notable transaction took place in January 2022, when Cumberland Pharmaceuticals Inc., a specialist pharmaceutical firm based in the US, acquired Sancuso (a granisetron transdermal patch) from Kyowa Kirin for $13.5 million. This deal gave Cumberland the US rights for Sancuso and responsibility for its marketing, promotion, distribution, manufacturing, and medical support. Sancuso is a prescription patch delivering granisetron through the skin to manage chemotherapy-induced nausea and vomiting. Kyowa Kirin, based in Japan, is a key manufacturer in this space.

View the full transdermal skin patches market report:
https://www.thebusinessresearchcompany.com/report/transdermal-skin-patche-global-market-report

Emerging Trends Highlighting Innovation in the Transdermal Skin Patches Market
Companies are focusing more on launching innovative products and securing approvals to differentiate themselves in this competitive market. Innovation here means introducing new or enhanced solutions such as novel drugs, devices, or product improvements that address unmet medical needs.
For instance, in March 2022, Noven Pharmaceuticals Inc. announced FDA approval for XELSTRY, the first and only amphetamine transdermal patch approved for treating ADHD. This patch is designed to be applied two hours before the desired effect and removed after nine hours, with dosage adjusted based on patient response and tolerance.

Detailed Segment Breakdown of the Transdermal Skin Patches Market
The transdermal skin patches market is segmented into several categories:
1) By Product Type: Matrix, Drug In Adhesive, Reservoir, Vapor
2) By Patch Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, and Other Types
3) By Application: Pain Relief, Nicotine Cessation, Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, and Other Applications

Further subcategories include:
- Matrix patches, which comprise drug-in-matrix and polymer matrix types
- Drug-in-adhesive patches where the drug is incorporated directly into the adhesive layer
- Reservoir patches featuring a separate drug compartment, including multi-layer variants
- Vapor patches that release active ingredients in vapor form and utilize vaporization technology

These classifications help provide a comprehensive understanding of the various technologies and uses within the transdermal skin patches market.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Analysis of Segments and Major Growth Areas in the Transdermal Skin Patches Market here

News-ID: 4318648 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the